StockWatch
·
Biotechnology: Pharmaceutical Preparations
AcquisitionsAug 3, 2026, 04:23 PM

CDT Equity Amends 8-K for Sarborg Acquisition Financials

AI Summary

CDT Equity Inc. filed an Amendment No. 1 to its Current Report on Form 8-K, originally filed on July 31, 2026. This amendment is to include information related to the Sarborg Limited investments, specifically regarding the completion of acquisition or disposition of assets (Item 2.01) and the required financial statements and pro forma financial information (Item 9.01(a) and (b)). The financial statements and pro forma information for the acquired business will be filed via an additional amendment within 71 calendar days.

Key Highlights

  • Amendment No. 1 to the original 8-K filed on July 31, 2026.
  • Purpose is to include Items 2.01, 9.01(a), and 9.01(b) regarding Sarborg Limited investments.
  • Item 2.01 (Completion of Acquisition) incorporates information from the original report.
  • Required financial statements for the acquired business will be filed via an additional amendment.
  • Pro forma financial information for the acquired business will also be filed via an additional amendment.
  • Both financial statements and pro forma information are due within 71 calendar days.
  • CDT Equity Inc. is an emerging growth company.